| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.62M | 38.80M | 42.19M | 41.42M | 38.95M | 40.88M |
| Gross Profit | 18.13M | 18.37M | 18.71M | 16.19M | 15.92M | 17.33M |
| EBITDA | -34.10M | -36.71M | 3.32M | 6.48M | 5.91M | 6.42M |
| Net Income | -38.20M | -39.29M | 384.00K | 385.00K | 156.00K | -225.00K |
Balance Sheet | ||||||
| Total Assets | 47.16M | 47.90M | 91.91M | 96.21M | 97.87M | 101.08M |
| Cash, Cash Equivalents and Short-Term Investments | 1.61M | 1.85M | 2.01M | 2.65M | 2.46M | 3.61M |
| Total Debt | 8.58M | 10.44M | 13.44M | 17.93M | 20.11M | 22.34M |
| Total Liabilities | 26.47M | 28.77M | 33.85M | 38.89M | 41.25M | 45.02M |
| Stockholders Equity | 20.69M | 19.13M | 58.06M | 57.32M | 56.62M | 56.06M |
Cash Flow | ||||||
| Free Cash Flow | 5.79M | 4.89M | 7.20M | 5.74M | 4.52M | 9.95M |
| Operating Cash Flow | 5.82M | 5.08M | 7.51M | 6.02M | 5.14M | 11.04M |
| Investing Cash Flow | -2.15M | -130.00K | -339.00K | -3.56M | -4.04M | -5.56M |
| Financing Cash Flow | -4.26M | -5.11M | -7.82M | -2.26M | -2.25M | -4.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £28.30M | 10.04 | 21.43% | 2.29% | 3.32% | -10.58% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | £4.20M | 10.00 | 4.93% | ― | ― | ― | |
56 Neutral | £63.76M | -5.98 | -32.35% | 4.09% | -13.72% | -361.92% | |
53 Neutral | £17.75M | -0.46 | -96.35% | ― | -4.96% | -4798.26% | |
49 Neutral | £17.67M | -6.72 | -3.81% | ― | -25.20% | 78.55% | |
48 Neutral | £17.93M | -1.43 | -37.24% | ― | -0.79% | -100.22% |
NAHL Group reported strong unaudited trading for the year to 31 December 2025, with revenues expected to rise 3% to about £40m and underlying operating profit up 86% to around £7.3m, driven mainly by higher revenue and lower marketing costs in its Personal Injury operations and the completion of intangible asset amortisation. Underlying profit before tax is set to more than triple to roughly £5m despite £0.6m of exceptional costs linked to the aborted sale of Bush & Co. and cost savings, while robust cash generation lifted free cash flow by 37% to £3.9m and cut net debt by 55% to a 10-year low of £3.2m, as the Board continues to review options to accelerate shareholder value. Consumer Legal Services delivered a 4% revenue increase and a 120% jump in underlying operating profit, supported by a strong performance at National Accident Law, which settled more claims and launched a Serious Injury team targeting higher-margin, complex cases, although a deliberate reduction in new enquiries to control acquisition costs and align with capacity is expected to weigh on the division’s 2026 results. The Critical Care division achieved modest revenue growth with flat profits, as Bush & Co.’s expert witness work remained strong, case management demand stayed soft, and newer offerings such as Bush & Co. Care Solutions and Bush & Co. Kids showed encouraging momentum, with new leadership and the cessation of the sale process allowing the Group to refocus on delivering profitable medium-term growth across both divisions.
The most recent analyst rating on (GB:NAH) stock is a Hold with a £36.00 price target. To see the full list of analyst forecasts on NAHL Group Plc stock, see the GB:NAH Stock Forecast page.
NAHL Group has granted 900,000 new share options to certain employees under its Group Share Option Plan, with no directors or persons discharging managerial responsibilities included in the award. The nominal-cost options, which vest in two tranches in April 2027 and April 2028 subject to continued employment and potential adjustment by the remuneration committee based on overall business performance, bring the total outstanding options to 2,428,570, representing 5.04% of the company’s current issued share capital, underscoring the group’s continued use of equity-based incentives to align staff interests with long-term shareholder value.
The most recent analyst rating on (GB:NAH) stock is a Hold with a £41.00 price target. To see the full list of analyst forecasts on NAHL Group Plc stock, see the GB:NAH Stock Forecast page.